BACKGROUND: Linkage to the US Renal Data System (USRDS) registry commonly is used to identify end-stage renal disease (ESRD) cases, or kidney failure treated with dialysis or transplantation, but it underestimates the total burden of kidney failure. This study validates a kidney failure definition that includes both kidney failure treated and not treated by dialysis or transplantation. It compares kidney failure risk factors and outcomes using this broader definition with USRDS-identified ESRD risk factors and outcomes. STUDY DESIGN: Diagnostic test study with stratified random sampling of hospitalizations for chart review. SETTING & PARTICIPANTS: Atherosclerosis Risk in Communities Study (n=11,530; chart review, n=546). INDEX TEST: USRDS-identified ESRD; treated or untreated kidney failure defined by USRDS-identified ESRD or International Classification of Diseases, Ninth or Tenth Revision, Clinical Modification (ICD-9-CM/ICD-10-CM) code for hospitalization or death. REFERENCE TEST: For ESRD, determination of permanent dialysis therapy or transplantation; for kidney failure, determination of permanent dialysis therapy, transplantation, or estimated glomerular filtration rate < 15 mL/min/1.73 m(2). RESULTS: During 13 years' median follow-up, 508 kidney failure cases were identified, including 173 (34.1%) from the USRDS registry. ESRD and kidney failure incidence were 1.23 and 3.66 cases per 1,000 person-years in the overall population and 1.35 and 6.59 cases per 1,000 person-years among participants older than 70 years, respectively. Other risk-factor associations were similar between ESRD and kidney failure, except diabetes and albuminuria, which were stronger for ESRD. Survivals at 1 and 5 years were 74.0% and 24.0% for ESRD and 59.8% and 31.6% for kidney failure, respectively. Sensitivity and specificity were 88.0% and 97.3% comparing the kidney failure ICD-9-CM/ICD-10-CM code algorithm to chart review; for USRDS-identified ESRD, sensitivity and specificity were 94.9% and 100.0%. LIMITATIONS: Some medical charts were incomplete. CONCLUSIONS: A kidney failure definition including treated and untreated disease identifies more cases than linkage to the USRDS registry alone, particularly among older adults. Future studies might consider reporting both USRDS-identified ESRD and a more inclusive kidney failure definition.
BACKGROUND: Linkage to the US Renal Data System (USRDS) registry commonly is used to identify end-stage renal disease (ESRD) cases, or kidney failure treated with dialysis or transplantation, but it underestimates the total burden of kidney failure. This study validates a kidney failure definition that includes both kidney failure treated and not treated by dialysis or transplantation. It compares kidney failure risk factors and outcomes using this broader definition with USRDS-identified ESRD risk factors and outcomes. STUDY DESIGN: Diagnostic test study with stratified random sampling of hospitalizations for chart review. SETTING & PARTICIPANTS: Atherosclerosis Risk in Communities Study (n=11,530; chart review, n=546). INDEX TEST: USRDS-identified ESRD; treated or untreated kidney failure defined by USRDS-identified ESRD or International Classification of Diseases, Ninth or Tenth Revision, Clinical Modification (ICD-9-CM/ICD-10-CM) code for hospitalization or death. REFERENCE TEST: For ESRD, determination of permanent dialysis therapy or transplantation; for kidney failure, determination of permanent dialysis therapy, transplantation, or estimated glomerular filtration rate < 15 mL/min/1.73 m(2). RESULTS: During 13 years' median follow-up, 508 kidney failure cases were identified, including 173 (34.1%) from the USRDS registry. ESRD and kidney failure incidence were 1.23 and 3.66 cases per 1,000 person-years in the overall population and 1.35 and 6.59 cases per 1,000 person-years among participants older than 70 years, respectively. Other risk-factor associations were similar between ESRD and kidney failure, except diabetes and albuminuria, which were stronger for ESRD. Survivals at 1 and 5 years were 74.0% and 24.0% for ESRD and 59.8% and 31.6% for kidney failure, respectively. Sensitivity and specificity were 88.0% and 97.3% comparing the kidney failure ICD-9-CM/ICD-10-CM code algorithm to chart review; for USRDS-identified ESRD, sensitivity and specificity were 94.9% and 100.0%. LIMITATIONS: Some medical charts were incomplete. CONCLUSIONS:A kidney failure definition including treated and untreated disease identifies more cases than linkage to the USRDS registry alone, particularly among older adults. Future studies might consider reporting both USRDS-identified ESRD and a more inclusive kidney failure definition.
Authors: Lorien S Dalrymple; Ronit Katz; Bryan Kestenbaum; Michael G Shlipak; Mark J Sarnak; Catherine Stehman-Breen; Stephen Seliger; David Siscovick; Anne B Newman; Linda Fried Journal: J Gen Intern Med Date: 2010-09-19 Impact factor: 5.128
Authors: Alessandro Gasparini; Marie Evans; Josef Coresh; Morgan E Grams; Olof Norin; Abdul R Qureshi; Björn Runesson; Peter Barany; Johan Ärnlöv; Tomas Jernberg; Björn Wettermark; Carl G Elinder; Juan-Jesüs Carrero Journal: Nephrol Dial Transplant Date: 2016-10-13 Impact factor: 5.992
Authors: Benjamin Lazarus; Yuan Chen; Francis P Wilson; Yingying Sang; Alex R Chang; Josef Coresh; Morgan E Grams Journal: JAMA Intern Med Date: 2016-02 Impact factor: 21.873
Authors: Casey M Rebholz; Morgan E Grams; Pamela L Lutsey; Andrew N Hoofnagle; Jeffrey R Misialek; Lesley A Inker; Andrew S Levey; Elizabeth Selvin; Chi-Yuan Hsu; Paul L Kimmel; Ramachandran S Vasan; John H Eckfeldt; Josef Coresh Journal: Am J Kidney Dis Date: 2015-10-23 Impact factor: 8.860
Authors: Yan Chen; Alex R Chang; Mara A McAdams DeMarco; Lesley A Inker; Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Morgan E Grams Journal: Mayo Clin Proc Date: 2016-08-04 Impact factor: 7.616
Authors: Morgan E Grams; Casey M Rebholz; Yuan Chen; Andreea M Rawlings; Michelle M Estrella; Elizabeth Selvin; Lawrence J Appel; Adrienne Tin; Josef Coresh Journal: J Am Soc Nephrol Date: 2016-03-10 Impact factor: 10.121
Authors: Matthew F Blum; Aditya Surapaneni; James D Stewart; Duanping Liao; Jeff D Yanosky; Eric A Whitsel; Melinda C Power; Morgan E Grams Journal: Clin J Am Soc Nephrol Date: 2020-02-27 Impact factor: 8.237
Authors: Emily A Hu; Elizabeth Selvin; Morgan E Grams; Lyn M Steffen; Josef Coresh; Casey M Rebholz Journal: Am J Kidney Dis Date: 2018-03-20 Impact factor: 8.860
Authors: Casey M Rebholz; Morgan E Grams; Lyn M Steffen; Deidra C Crews; Cheryl A M Anderson; Lydia A Bazzano; Josef Coresh; Lawrence J Appel Journal: Clin J Am Soc Nephrol Date: 2016-10-26 Impact factor: 8.237
Authors: Adrienne Tin; Robert Scharpf; Michelle M Estrella; Bing Yu; Megan L Grove; Patricia P Chang; Kunihiro Matsushita; Anna Köttgen; Dan E Arking; Eric Boerwinkle; Thu H Le; Josef Coresh; Morgan E Grams Journal: J Am Soc Nephrol Date: 2017-07-18 Impact factor: 10.121
Authors: Casey M Rebholz; Elizabeth Selvin; Menglu Liang; Christie M Ballantyne; Ron C Hoogeveen; David Aguilar; John W McEvoy; Morgan E Grams; Josef Coresh Journal: Kidney Int Date: 2017-08-31 Impact factor: 10.612